Absence of PML decreases the co-localization of DAXX and ATRX but not HIRA and UBN1 with latent/quiescent HSV-1 genomes. by Camille Cohen (2440810)

Growth index in 2003 as a function of mean infection index in 2001–2002 for two sites. by Didier Bert (3171177)

Trends in the proportion of patients with advanced stage of HIV infection (<200 CD4 cells/μL) at diagnosis among participants to the HIV-positive cohort at the <i>Clinique médicale... by Katia Giguère (146393)

Subjects:

Trends in the proportion of patients with late stage of HIV infection (<350 CD4 cells/μL) at diagnosis among participants to the HIV-positive cohort at the <i>Clinique médicale l’A... by Katia Giguère (146393)

Subjects:

Association of Medicare eligibility and enrollment at age 65 years on healthcare access, prescription medications, and financial strain by education level¹. by Rahul Aggarwal (4428457)

(a) Average speed, and (b) steering wheel variability per condition. by Germán Gálvez-García (8888069)

A Functional 12T-Insertion Polymorphism in the <i>ATP1A1</i> Promoter Confers Decreased Susceptibility to Hypertension in a Male Sardinian Population by Victoria L. Herrera (383897)

Subjects:

Scatter and line plots of cluster number and mean cluster size as wgs percentage in mixture increases, subset dataset. by August Guang (9975678)

Subjects:

Scatter and line plots of cluster number and mean cluster size as wgs percentage in mixture increases, full dataset. by August Guang (9975678)

Subjects:

Eradication of established biofilms of MRSA and MSSA by a range of concentrations of eugenol. by Mukesh Kumar Yadav (703688)

“…<p>(A) Decreased biomasses of established biofilms, detected by microtiter plate assay. …”

Promoter reporter studies for reported <i>NR5A1</i> mutations by Jana Malikova (615672)

Subjects:

Decreased weight loss in FI-A2 and G-A2 peptide vaccinated mice after RSV challenge. by Gertrud U. Rey (501694)

Promoter reporter studies for SF-1 regulating the human <i>BDNF</i> promoter I and comparative studies of specific <i>NR5A1</i> mutations on <i>BDNF</i> promoter activity. by Jana Malikova (615672)

Subjects:

Integrin expression decreased in treated tumors. by Anthony B. Eason (6294305)

Evolution of age at HIV diagnosis among participants to the HIV-positive cohort at the <i>Clinique médicale l’Actuel</i> in Montréal (Canada) over 1995–2019 (n = 2,612). by Katia Giguère (146393)

Subjects:

Relative Aggrecan mRNA expression levels, as measured by qPCR, in lentiviral-transduced control cells and 5 AggKD cell lines confirm decreased Aggrecan expression in the AggKD cell... by Juanita K. Hodax (6848540)

Mutation in <i>barA</i> or <i>uvrY</i> decrease and <i>csrA</i> increase hemolysis of sheep erythrocytes. by Senthilkumar Palaniyandi (285494)

Effect of statins in preventing a 3MC-mediated decrease in cell-cycle regulatory proteins and in DNA incorporation induced by RhoA inactivation. by Chih-Cheng Chang (540973)

Image_3_No Evidence for a Decrease in Physical Activity Among Swiss Office Workers During COVID-19: A Longitudinal Study.PDF by Andrea Martina Aegerter (10127111)

“…Weak statistical evidence for a decline in total physical activity in metabolic equivalent of task minutes per week (MET min/week) was found (estimate = −292, 95% CI from – ∞ to 74, p-value = 0.09), with no evidence for a decrease in the three types of activity: walking (estimate = −189, 95% CI from – ∞ to 100, p-value = 0.28), moderate-intensity activity (estimate = −200, 95% CI from – ∞ to 30, p-value = 0.22) and vigorous-intensity activity (estimate = 80, 95% CI from – ∞ to 460, p-value = 0.74). …”

Image_1_No Evidence for a Decrease in Physical Activity Among Swiss Office Workers During COVID-19: A Longitudinal Study.TIFF by Andrea Martina Aegerter (10127111)

“…Weak statistical evidence for a decline in total physical activity in metabolic equivalent of task minutes per week (MET min/week) was found (estimate = −292, 95% CI from – ∞ to 74, p-value = 0.09), with no evidence for a decrease in the three types of activity: walking (estimate = −189, 95% CI from – ∞ to 100, p-value = 0.28), moderate-intensity activity (estimate = −200, 95% CI from – ∞ to 30, p-value = 0.22) and vigorous-intensity activity (estimate = 80, 95% CI from – ∞ to 460, p-value = 0.74). …”